We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

189 hedge funds and large institutions have $1.43B invested in Corcept Therapeutics in 2017 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 65 increasing their positions, 46 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

262% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 13

139% more call options, than puts

Call options by funds: $11.7M | Put options by funds: $4.89M

73% more capital invested

Capital invested by funds: $824M → $1.43B (+$605M)

41% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 46

21% more funds holding

Funds holding: 156 → 189 (+33)

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

3.67% more ownership

Funds ownership: 61.7% → 65.37% (+3.7%)

Holders
189
Holders Change
+33
Holders Change %
+21.15%
% of All Funds
4.71%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.15%
New
47
Increased
65
Reduced
46
Closed
13
Calls
$11.7M
Puts
$4.89M
Net Calls
+$6.79M
Net Calls Change
+$5.06M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$26.8M
2
Renaissance Technologies
Renaissance Technologies
New York
+$14.7M
3
Wells Fargo
Wells Fargo
California
+$9.23M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$8.89M
5
AAM
AMI Asset Management
California
+$7.87M

Top Sellers

1
Federated Hermes
Federated Hermes
Pennsylvania
-$33.2M
2
CCM
Consonance Capital Management
New York
-$28.7M
3
MWNA
Marshall Wace North America
New York
-$10.4M
4
ISL
Ingalls & Snyder LLC
New York
-$6.46M
5
Morgan Stanley
Morgan Stanley
New York
-$6.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
51
Timpani Capital Management
Wisconsin
$3.35M +$715K +47,923 +38%
California Public Employees Retirement System
52
California Public Employees Retirement System
California
$3.13M +$213K +14,259 +10%
GCP
53
GSA Capital Partners
United Kingdom
$2.92M +$826K +55,400 +58%
IP
54
Intellectus Partners
California
$2.88M -$15.7K -1,050 -0.7%
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$2.82M -$231K -15,512 -10%
Fuller & Thaler Asset Management
56
Fuller & Thaler Asset Management
California
$2.8M +$1.34M +89,700 +162%
PPA
57
Parametric Portfolio Associates
Washington
$2.79M +$796K +53,381 +58%
TCM
58
Tanaka Capital Management
New York
$2.7M +$7.01K +470 +0.3%
American Century Companies
59
American Century Companies
Missouri
$2.69M +$2.08M +139,360 New
Swiss National Bank
60
Swiss National Bank
Switzerland
$2.68M – – –
CEP
61
Chicago Equity Partners
Illinois
$2.64M +$919K +61,615 +82%
AWS
62
AJ Wealth Strategies
New York
$2.55M -$31.1K -2,083 -2%
Citadel Advisors
63
Citadel Advisors
Florida
$2.54M -$396K -26,558 -17%
ARTA
64
A.R.T. Advisors
New York
$2.51M +$1.94M +129,914 New
AP
65
AHL Partners
United Kingdom
$2.37M +$1.83M +122,993 New
CIP
66
Convergence Investment Partners
Florida
$2.31M +$125K +8,371 +8%
DCM
67
Dupont Capital Management
Delaware
$2.27M – – –
JIR
68
James Investment Research
Ohio
$2.27M +$1.75M +117,400 New
3C
69
361 Capital
Colorado
$2.23M +$1.18M +79,161 +218%
CS
70
Credit Suisse
Switzerland
$2.21M +$713K +47,842 +72%
SI
71
Shaker Investments
Ohio
$2.2M +$1.7M +114,085 New
VRS
72
Virginia Retirement Systems
Virginia
$2.09M +$1.46M +97,700 +905%
CCMH
73
Cornerstone Capital Management Holdings
New York
$2.02M +$1.14M +76,500 +268%
New York State Common Retirement Fund
74
New York State Common Retirement Fund
New York
$1.88M – – –
BC
75
Birchview Capital
Vermont
$1.83M – – –
1 2
3
4 5

CORT Hedge Fund Activity: Q3 2017 in Review

189 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q3 2017, worth a combined $1.43B — up 73% from $824M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new CORT positions and 13 closed out — a net gain of 34 holders — while 65 added to existing stakes and 46 trimmed.

The largest buyer was Vanguard Group, adding an estimated $26.8M. The largest seller was Federated Hermes, cutting an estimated $33.2M.

  • 189 institutional investors held Corcept Therapeutics (CORT) as of Q3 2017, up from 156 in Q2 2017.
  • Funds reported $1.43B of Corcept Therapeutics stock for Q3 2017, up 73% quarter-over-quarter.
  • 47 funds opened new Corcept Therapeutics positions in Q3 2017 and 13 closed out, a net change of +34 holders.
  • The largest Corcept Therapeutics buyer in Q3 2017 was Vanguard Group, an estimated $26.8M added.
  • The largest Corcept Therapeutics seller in Q3 2017 was Federated Hermes, an estimated $33.2M sold.

Based on aggregated 13F filings for Q3 2017.